|
[1]
|
Bray, F., Ferlay, J., Soerjiomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancer in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Roxburgh, C.S. and McMillan, D.C. (2012) The Role of the in Situ Local Inflammatory Response in Predicting Recurrence and Survival in Patients with Primary Operable Colorectal Cancer. Cancer Treatment Reviews, 38, 451-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Davey, M.S., Willcox, C.R., Joyce, S.P., Ladell, K., Kasatskaya, S.A., McLaren, J.E., et al. (2017) Clonal Selection in the Human Vδ1 T Cell Repertoire Indicates γδ TCR-Dependent Adaptive Immune Surveillance. Nature Communications, 8, Article No. 14760. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Davey, M.S., Willcox, C.R., Hunter, S., Kasatskaya, S.A., Remmerswaal, E.B.M., Salim, M., et al. (2018) The Human Vδ2+ T-Cell Compartment Comprises Distinct Innate-Like Vγ9+ and Adaptive Vγ9− Subsets. Nature Communications, 9, Article No. 1760. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Davey, M.S., Willcox, C.R., Baker, A.T., Hunter, S. and Willcox, B.E. (2018) Recasting Human Vδ1 Lymphocytes in an Adaptive Role. Trends in Immunology, 39, 446-459. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Lafont, V., Sanchez, F., Laprevotte, E., Michaud, H.-A., Gros, L., Eliaou, J.-F., et al. (2014) Plasticity of Gammadelta T Cells: Impact on the Antitumor Response. Frontiers in Immunology, 5, Article No. 622. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wu, Y.L., Ding, Y.P., Tanaka, Y., Shen, L.W., Wei, C.H., Minato, N., et al. (2014) γδ T Cells and Their Potential for Immunotherapy. International Journal of Biological Sciences, 10, 119-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ferreira, L.M. (2013) Gammadelta T Cells: Innately Adaptive Immune Cells. International Reviews of Immunology, 32, 223-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Born, W.K., Reardon, C.L. and O’Brien, R.L. (2006) The Function of γδ T Cells in Innate Immunity. Current Opinion in Immunology, 18, 31-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Dokouhaki, P., Han, M., Joe, B., Li, M., Johnston, M.R., Tsao, M.-S., et al. (2010) Adoptive Immunotherapy of Cancer Using ex Vivo Expanded Human γδ T Cells: A New Approach. Cancer Letters, 297, 126-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Coffelt, S.B., Kersten, K., Doornebal, C.W., Weiden, J., Vrijland, K., Hau, C.-S., et al. (2015) IL-17-Producing γδ T Cells and Neutrophils Conspire to Promote Breast Cancer Metastasis. Nature, 522, 345-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Bank, I., Book, M., Huszar, M., Baram, Y., Schnirer, I. and Brenner, H. (1993) Vδ2+ γδ T Lymphocytes Are Cytotoxic to the MCF 7 Breast Carcinoma Cell Line and Can Be Detected among the T Cells That Infiltrate Breast Tumors. Clinical Immunology & Immunopathology, 67, 17-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Guo, B.L., Liu, Z., Aldrich, W.A. and Lopez, R.D. (2005) Innate Anti-Breast Cancer Immunity of Apoptosis-Resistant Human γδ-T Cells. Breast Cancer Research & Treatment, 93, 69-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Beck, B.H., Kim, H.G., Kim, H., Samuel, S., Liu, Z., Shrestha, R., et al. (2010) Adoptively Transferred ex Vivo expanded γδ-T Cells Mediate in Vivo Antitumor Activity in Preclinical Mouse Models of Breast Cancer. Breast Cancer Research & Treatment, 122, 135-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Aggarwal, R., Lu, J., Kanji, S., Das, M., Joseph, M., Lustberg, M.B., et al. (2013) Human Vγ2Vδ2 T Cells Limit Breast Cancer Growth by Modulating Cell Survival-, Apoptosis-Related Molecules and Microenvironment in Tumors. International Journal of Cancer, 133, 2133-2144. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Willcox, C.R., Pitard, V., Netzer, S., Couzi, L., Salim, M., Silberzahn, T., et al. (2012) Cytomegalovirus and Tumor Stress Surveillance by Binding of a Human γδ T Cell Antigen Receptor to Endothelial Protein C Receptor. Nature Immunology, 13, 872-879. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gaafar, A., Aljurf, M.D., Al-Sulaiman, A., Iqniebi, A., Manogaran, P.S., Mohamed, G.E.H., et al. (2009) Defective γδ T-Cell Function and Granzyme B Gene Polymorphism in a Cohort of Newly Diagnosed Breast Cancer Patients. Experimental Hematology, 37, 838-848. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sugie, T., Murata-Hirai, K., Iwasaki, M., Morita, C.T., Li, W., Okamura, H., et al. (2013) Zoledronic Acid-Induced Expansion of γδ T Cells from Early-Stage Breast Cancer Patients: Effect of IL-18 on Helper NK Cells. Cancer Immunology Immunotherapy, 62, 677-687. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ma, C., Zhang, Q., Ye, J., Wang, F., Zhang, Y., Wevers, E., et al. (2012) Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer. Journal of Immunology, 189, 5029-5036. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ye, J., Ma, C., Hsueh, E.C., Eickhoff, C.S., Zhang, Y., Varvares, M.A., et al. (2013) Tumor-Derived γδ Regulatory T Cells Suppress Innate and Adaptive Immunity through Theinduction of Immunosenescence. Journal of Immunology, 190, 2403-2414. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Hidalgo, J.V., Bronsert, P., Orlowska-Volk, M., Díaz, L.B., Stickeler, E., Werner, M., et al. (2014) Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas. Frontiers in Immunology, 5, Article No. 632. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Peng, G., Wang, H.Y., Peng, W., Kiniwa, Y., Seo, K.H., Wang, R.-F., et al. (2007) Tumor-Infiltrating γδ T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-Like Receptor Signaling Pathway. Immunity, 27, 334-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hamilton, E., Clay, T.M. and Blackwell, K.L. (2011) New Perspectives on Zoledronic Acid in Breast Cancer: Potential Augmentation of Anticancer Immune Response. Cancer Investigation, 29, 533-541. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Benzaid, I., Monkkonen, H., Stresing, V., Bonnelye, E., Green, J., Mönkkönen, J., et al. (2011) High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity in Vivo. Cancer Research, 71, 4562-4572. [Google Scholar] [CrossRef]
|
|
[26]
|
Zhao, Y., Niu, C. and Cui, J. (2018) Gamma-Delta (γδ) T Cells: Friend or Foe in Cancer Development. Journal of Translational Medicine, 16, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Zysk, A., DeNichilo, M.O., Panagopoulos, V., Zinonos, I., Liapis, V., Hay, S., et al. (2017) Adoptive Transfer of ex Vivo Expanded Vγ9Vδ2 T Cells in Combination with Zoledronic Acid Inhibits Cancer Growth and Limits Osteolysis in a Murine Model of Osteolytic Breast Cancer. Cancer Letters, 86, 141-150. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Capietto, A.H., Martinet, L. and Fournie, J.J. (2011) Stimulated Gammadelta T Cells Increase the in Vivo Efficacy of Trastuzumab in HER2+ Breast Cancer. Journal of Immunology, 187, 1031-1038. [Google Scholar] [CrossRef] [PubMed]
|